Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience

INTRODUCTION: Whether biologic therapies enhance the risk of coronavirus 2019 (COVID-19) or affect the disease outcome in patients with chronic plaque psoriasis remains to be ascertained. OBJECTIVE: We sought to investigate the incidence of hospitalization and death for COVID-19 in a large sample of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gisondi, Paolo, Piaserico, Stefano, Naldi, Luigi, Dapavo, Paolo, Conti, Andrea, Malagoli, Piergiorgio, Marzano, Angelo Valerio, Bardazzi, Federico, Gasperini, Massimo, Cazzaniga, Simone, Costanzo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644231/
https://www.ncbi.nlm.nih.gov/pubmed/33160968
http://dx.doi.org/10.1016/j.jaci.2020.10.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644231/
https://www.ncbi.nlm.nih.gov/pubmed/33160968
http://dx.doi.org/10.1016/j.jaci.2020.10.032

Ejemplares similares